Clinical Trial

Telpegfilgrastim Injection to Reduce the Risk of Neutropenia in Patients With Solid Tumor

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 31, 2025 (before its estimated August 15, 2025 completion). Its status may not reflect the trial's current state.
Summary
The objective of this real world study is to confirm the efficacy and saftey of Telpegfilgrastim injection for the prevention of chemotherapy-induced Neutropenia in Patients With Malignant solid tumor.
Trial Details
NCT Number NCT07096479
Lead Sponsor Anhui Provincial Hospital
Conditions Chemotherapy-induced Neutropenia
Enrollment 318 participants
Start Date 2024-08-15
Primary Completion 2025-08-15 (estimated)
Study Completion 2025-08-15 (estimated)
Updated on ClinicalTrials.gov 2025-07-31